RESEARCH EXPERIENCE

We have succesfully conducted 22 studies in the last 24 months and currently initiating 12 new ones. We have been World Top Enrollers in 4 studies and top enrollers in Latin America in 2 more. This year we have been awarded with the prize to Research Excellency for our high level of commitment and quality of work.

Efficacy and Safety of Insulin Glargine/ Lixisenatide Fixed Ratio Combination Compared to Insulin Glargine Alone and Lixisenatide Alone on Top of Metformin in Patients With T2DM

Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes

Ertugliflozin and Sitagliptin Co-administration Factorial Study

Efficacy and Safety of ABT-494 Given With Methotrexate (MTX) in Subjects With Rheumatoid Arthritis Who Have Had an Inadequate Response to MTX Alone

Open-label Extension Study Evaluating the Safety and Efficacy of ABT-494 in Rheumatoid Arthritis Subjects<

A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients

A Study to Compare FKB327 Long-term Safety, Efficacy and Immunogenicity With Humira® in Rheumatoid Arthritis Patients Effectiveness and Safety of CNTO 136 in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy

Efficacy and Safety Study Evaluating Tofacitinib with and without Methotrexate Compared to Adalimumab with Methotrexate

Efficacy and Safety of Sarilumab and Adalimumab Monotherapy in Patients with Rheumatoid Arthritis

BI 695501 Compared to Adalimumab in Patients with active Rheumatoid Arthritis

​​ Long-term Assessment of Safety and Efficacy of BI 695501 in Patients With Rheumatoid Arthritis

Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus Long-term Safety and Tolerability of Atacicept

Treatment of Pain associated with Fibromyalgia: DS5565 versus Pregabalin

Treatment of Neuropathic Pain associated with Diabetic Peripheral Neuropathy

Evaluation of Bococizumab (PF-04950615;RN316) in reducing the occurrence of major cardiovascular events in high risk subjects

Efficacy and Safety Study of Dapirolizumab Pegol (DZP) in Systemic Lupus Erythematosus

Evaluation of Dupilumab in Patients with Persistent Asthma

Study Of Diabetic Nephropathy with Atrasentan

Efficacy and Safety of PT010 relative to PT003 and PT009 in Subjects With Moderate to Very Severe COPD

A Study Comparing ABT-494 to Placebo in Subjects With Rheumatoid Arthritis on a Stable Dose of Conventional Synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs) who have an inadequate response to csDMARDs alone

 

A Study to compare ABT-494 Monotherapy to Methotrexate Monotherapy in subjects with Rheumatoid Arthritis (RA) who have not previously taken Methotrexate

A Study Comparing ABT-494 to Placebo and to Adalimumab in Subjects With Rheumatoid Arthritis Who Are on a Stable Dose of Methotrexate and Who Have an Inadequate Response to Methotrexate

A Study Comparing ABT-494 Monotherapy to Methotrexate (MTX) Monotherapy in Subjects With Rheumatoid Arthritis (RA) Who Have an Inadequate Response to MTX

Study to Evaluate the Efficacy and Safety of BMS-931699 (Lulizumab) or BMS-986142 in Primary Sjögren's Syndrome

​​ Study to Assess the Efficacy and Safety of H.P. Acthar® Gel in Subjects With Rheumatoid Arthritis

Please reload

RHEUMA

PAIN

RESPIRATORY

DIABETES

CARDIOLOGY

RHEUMA

Contact US

PUERTO VARAS

Dr Otto Bader 810, Puerto Varas, 5550170, Chile.

Phone: +56 652582481   Fax: +56 652582480

SANTIAGO

General del Canto 105, of 505, Providencia, Santiago, 7500588, Chile.

 Tel: +56 232238332   Fax: +56 232238334

info@quantumresearch.cl